Page last updated: 2024-08-22

camptothecin and Dysesthesia

camptothecin has been researched along with Dysesthesia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishikawa, H; Kamakari, K; Noguchi, T; Ono, N; Tashima, M; Terada, Y	1
Fung, A; Viale, PH; Zitella, L	1
Boige, V; Cohen, M; Delbaldo, C; Faivre, S; Namouni, F; Pautier, P; Peck, R; Raymond, E; Soria, JC	1

Reviews

1 review(s) available for camptothecin and Dysesthesia

Article	Year
Advanced colorectal cancer: current treatment and nursing management with economic considerations. Clinical journal of oncology nursing, 2005, Volume: 9, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cause of Death; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Costs; Drug Hypersensitivity; Drug Industry; Female; Fluorouracil; Humans; Irinotecan; Male; Medical Assistance; Nausea; Neoplasm Staging; Nurse's Role; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Patient Education as Topic; Treatment Outcome; United States; Vomiting	2005

Article

Year

Advanced colorectal cancer: current treatment and nursing management with economic considerations.

Clinical journal of oncology nursing, 2005, Volume: 9, Issue:5

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cause of Death; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Costs; Drug Hypersensitivity; Drug Industry; Female; Fluorouracil; Humans; Irinotecan; Male; Medical Assistance; Nausea; Neoplasm Staging; Nurse's Role; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Patient Education as Topic; Treatment Outcome; United States; Vomiting

2005

Trials

1 trial(s) available for camptothecin and Dysesthesia

Article	Year
Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies. European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Diarrhea; Dose-Response Relationship, Drug; Epothilones; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Nausea; Neoplasms; Paresthesia; Vomiting	2008

Article

Year

Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies.

European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:5

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Diarrhea; Dose-Response Relationship, Drug; Epothilones; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Nausea; Neoplasms; Paresthesia; Vomiting

2008

Other Studies

1 other study(ies) available for camptothecin and Dysesthesia

Article	Year
[A case of paraneoplastic syndrome improved following chemoradiotherapy for lung cancer]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2003, Volume: 41, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Gait Ataxia; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Polyneuropathy; Paresthesia; Radiotherapy, Adjuvant; Treatment Outcome	2003

Article

Year

[A case of paraneoplastic syndrome improved following chemoradiotherapy for lung cancer].

Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2003, Volume: 41, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Gait Ataxia; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Polyneuropathy; Paresthesia; Radiotherapy, Adjuvant; Treatment Outcome

2003